首页> 美国卫生研究院文献>Molecules >Panax Notoginseng Saponins as a Novel Nature Stabilizer for Poorly Soluble Drug Nanocrystals: A Case Study with Baicalein
【2h】

Panax Notoginseng Saponins as a Novel Nature Stabilizer for Poorly Soluble Drug Nanocrystals: A Case Study with Baicalein

机译:三七总皂苷作为难溶性药物纳米晶体的新型自然稳定剂:以黄ical素为例的研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study is aimed at seeking a nature saponin-based stabilizer for drug nanosuspensions. A poorly soluble drug (baicalein, BCL) was used as a model drug. BCL nanosuspensions with particle size of 156 nm were prepared by means of homogenization and converted into BCL nanocrystals (BCL-NC) stabilized with panax notoginseng saponins (PNS). It was found that PNS was able to prevent the aggregation of BCL-NS during storage and improve the redispersibility of BCL-NC after freeze-drying and spray-drying, compared with polymer stabilizer PVPK30. The freeze-dried and spray-dried BCL-NC with PNS exhibited excellent performance as evidenced by scanning_electron_microscope (SEM) analysis. It was the reason that PNS possessed the interfacial property (41.69 ± 0.32 mN/m) and electrostatic effect (−40.1 ± 1.6 mV), which could easily adsorb onto the surface of hydrophobic BCL nanocrystals and prevent from its aggregation. It is concluded that PNS can be used as an effective nature stabilizer for production of drug nanocrystals.
机译:这项研究旨在寻找一种基于天然皂素的稳定剂,用于药物纳米悬浮液。难溶性药物(黄ical素,BCL)用作模型药物。通过均质化制备粒径为156 nm的BCL纳米悬浮液,并将其转化为用三七总皂苷(PNS)稳定的BCL纳米晶体(BCL-NC)。发现与聚合物稳定剂PVPK30相比,PNS能够在储存过程中防止BCL-NS聚集,并改善了冷冻干燥和喷雾干燥后BCL-NC的再分散性。扫描电子显微镜(SEM)分析证明,带有PNS的冷冻干燥和喷雾干燥BCL-NC表现出优异的性能。这是PNS具有界面特性(41.69±0.32 mN / m)和静电效应(-40.1±1.6 mV)的原因,该特性易于吸附到疏水性BCL纳米晶体的表面并防止其聚集。结论是PNS可以用作生产药物纳米晶体的有效性质稳定剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号